Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Change in Accured Expenses (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Change in Accured Expenses for 3 consecutive years, with $14.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 171.29% year-over-year to $14.8 million, compared with a TTM value of $32.0 million through Dec 2025, up 122.14%, and an annual FY2025 reading of $32.0 million, up 122.14% over the prior year.
  • Change in Accured Expenses was $14.8 million for Q4 2025 at BrightSpring Health Services, down from $60.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $89.7 million in Q3 2023 and bottomed at -$110.5 million in Q2 2024.
  • Average Change in Accured Expenses over 3 years is $6.8 million, with a median of $11.7 million recorded in 2025.
  • The sharpest move saw Change in Accured Expenses tumbled 409.32% in 2024, then skyrocketed 1472.59% in 2025.
  • Year by year, Change in Accured Expenses stood at $34.3 million in 2023, then tumbled by 84.1% to $5.5 million in 2024, then surged by 171.29% to $14.8 million in 2025.
  • Business Quant data shows Change in Accured Expenses for BTSG at $14.8 million in Q4 2025, $60.7 million in Q3 2025, and -$52.1 million in Q2 2025.